ORMP
Price
$2.16
Change
-$0.02 (-0.92%)
Updated
Jul 7, 04:59 PM (EDT)
Capitalization
89.05M
37 days until earnings call
VXRT
Price
$0.33
Change
-$0.11 (-25.00%)
Updated
Jul 7, 04:59 PM (EDT)
Capitalization
73.03M
30 days until earnings call
Interact to see
Advertisement

ORMP vs VXRT

Header iconORMP vs VXRT Comparison
Open Charts ORMP vs VXRTBanner chart's image
Oramed Pharmaceuticals
Price$2.16
Change-$0.02 (-0.92%)
Volume$600
Capitalization89.05M
Vaxart
Price$0.33
Change-$0.11 (-25.00%)
Volume$281.89K
Capitalization73.03M
ORMP vs VXRT Comparison Chart in %
Loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VXRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORMP vs. VXRT commentary
Jul 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORMP is a Hold and VXRT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 08, 2025
Stock price -- (ORMP: $2.16 vs. VXRT: $0.32)
Brand notoriety: ORMP and VXRT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORMP: 58% vs. VXRT: 393%
Market capitalization -- ORMP: $88.24M vs. VXRT: $73.03M
ORMP [@Biotechnology] is valued at $88.24M. VXRT’s [@Biotechnology] market capitalization is $73.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORMP’s FA Score shows that 0 FA rating(s) are green whileVXRT’s FA Score has 1 green FA rating(s).

  • ORMP’s FA Score: 0 green, 5 red.
  • VXRT’s FA Score: 1 green, 4 red.
According to our system of comparison, VXRT is a better buy in the long-term than ORMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORMP’s TA Score shows that 3 TA indicator(s) are bullish while VXRT’s TA Score has 5 bullish TA indicator(s).

  • ORMP’s TA Score: 3 bullish, 6 bearish.
  • VXRT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VXRT is a better buy in the short-term than ORMP.

Price Growth

ORMP (@Biotechnology) experienced а -4.00% price change this week, while VXRT (@Biotechnology) price change was -29.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.42%. For the same industry, the average monthly price growth was +12.24%, and the average quarterly price growth was -0.68%.

Reported Earning Dates

ORMP is expected to report earnings on Aug 13, 2025.

VXRT is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Biotechnology (+3.42% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($89.1M) has a higher market cap than VXRT($73M). ORMP YTD gains are higher at: -9.917 vs. VXRT (-51.669). ORMP has higher annual earnings (EBITDA): -21.53M vs. VXRT (-45.73M). ORMP has more cash in the bank: 131M vs. VXRT (41.9M). ORMP has less debt than VXRT: ORMP (301K) vs VXRT (16.8M). VXRT has higher revenues than ORMP: VXRT (47.4M) vs ORMP (2M).
ORMPVXRTORMP / VXRT
Capitalization89.1M73M122%
EBITDA-21.53M-45.73M47%
Gain YTD-9.917-51.66919%
P/E Ratio20.91N/A-
Revenue2M47.4M4%
Total Cash131M41.9M313%
Total Debt301K16.8M2%
FUNDAMENTALS RATINGS
ORMP vs VXRT: Fundamental Ratings
ORMP
VXRT
OUTLOOK RATING
1..100
5078
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
25
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9398
PRICE GROWTH RATING
1..100
6262
P/E GROWTH RATING
1..100
53100
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VXRT's Valuation (25) in the Biotechnology industry is somewhat better than the same rating for ORMP (58) in the Pharmaceuticals Other industry. This means that VXRT’s stock grew somewhat faster than ORMP’s over the last 12 months.

VXRT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that VXRT’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's SMR Rating (93) in the Pharmaceuticals Other industry is in the same range as VXRT (98) in the Biotechnology industry. This means that ORMP’s stock grew similarly to VXRT’s over the last 12 months.

ORMP's Price Growth Rating (62) in the Pharmaceuticals Other industry is in the same range as VXRT (62) in the Biotechnology industry. This means that ORMP’s stock grew similarly to VXRT’s over the last 12 months.

ORMP's P/E Growth Rating (53) in the Pharmaceuticals Other industry is somewhat better than the same rating for VXRT (100) in the Biotechnology industry. This means that ORMP’s stock grew somewhat faster than VXRT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ORMPVXRT
RSI
ODDS (%)
Bearish Trend 5 days ago
74%
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
83%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 5 days ago
80%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 5 days ago
79%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
79%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 25 days ago
74%
Declines
ODDS (%)
Bearish Trend 11 days ago
83%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
82%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VXRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LEMIF0.11N/A
+1.77%
Leading Edge Materials Corp.
PECGF0.84N/A
N/A
Petronas Chemicals Group Bhd
SHZNY41.00N/A
N/A
Shenzhen Expressway Corporation Limited
CHMX5.37N/A
N/A
Next-ChemX Corporation
MAYX5.55N/A
N/A
Mayex USA, Inc.

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BTAI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BTAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
+0.93%
BTAI - ORMP
44%
Loosely correlated
N/A
INO - ORMP
44%
Loosely correlated
-37.85%
MBIO - ORMP
44%
Loosely correlated
N/A
VERV - ORMP
44%
Loosely correlated
+0.62%
ZNTL - ORMP
43%
Loosely correlated
N/A
More